JunHong Xing, TianMing Niu, Tong Yu, BoShi Zou, ShuHui Fan, ChunFeng Wang, ChunWei Shi, DongXing Zhang, Nan Wang, YanLong Jiang, HaiBin Huang, Xin Cao, Yan Zeng, JianZhong Wang, Di Zhang, GuiLian Yang, WenTao Yang
H9N2 influenza virus infections represent a significant respiratory health concern, yet the functional role of gut microbiota during infection progression remains poorly understood. Here, we show that H9N2 infection causes dose-dependent alterations in gut microbial communities in a mammalian infection model, particularly the depletion of Prevotella species. Prophylactic administration of Prevotella copri improved survival and clinical outcomes in infected mice by restructuring the gut microbiome, promoting beneficial bacteria, and suppressing pathogens. Metabolomic profiling revealed increased isovaleric acid levels in the intestine and serum. Isovaleric acid pretreatment reduced pulmonary inflammation, alleviated tissue damage, and preserved epithelial integrity. Isovaleric acid pretreatment alleviates lung inflammation, reduces tissue damage, and maintains epithelial integrity. Additionally, isovaleric acid mitigates infection caused by the H1N1 influenza virus. These findings highlight the immunomodulatory role of gut commensals and their metabolites in antiviral defense, offering a new approach to influenza virus treatment.
Microb Pathog. 2021 Nov;160:105204
[PMID:
34562554]
J Anim Sci Biotechnol. 2023 Jan 6;14(1):4
[PMID:
36604758]
Gut. 2023 Nov;72(11):2112-2122
[PMID:
37491158]
Gut. 2022 Mar;71(3):521-533
[PMID:
33685966]
BMC Microbiol. 2021 Jan 11;21(1):23
[PMID:
33430782]
J Pak Med Assoc. 2022 Oct;72(10):2112-2113
[PMID:
36661010]
Science. 2015 Jan 16;347(6219):266-9
[PMID:
25431490]
Benef Microbes. 2020 Sep 1;11(5):411-455
[PMID:
32865024]
Proc Nutr Soc. 2021 Feb;80(1):37-49
[PMID:
32238208]
Gut Microbes. 2024 Jan-Dec;16(1):2401649
[PMID:
39388633]
Dig Dis Sci. 2019 May;64(5):1171-1181
[PMID:
30560338]
Front Public Health. 2023 Dec 08;11:1255969
[PMID:
38155898]
Nat Commun. 2020 Sep 8;11(1):4457
[PMID:
32901017]
Nat Commun. 2022 Jun 9;13(1):3321
[PMID:
35680890]
Hepatology. 2023 Jan 1;77(1):48-64
[PMID:
35262957]
Vet Res. 2024 Oct 11;55(1):136
[PMID:
39390593]
J Med Virol. 2021 Aug;93(8):4638-4646
[PMID:
33792930]
Mayo Clin Proc. 2010 Jan;85(1):64-76
[PMID:
20007905]
J Gen Virol. 2023 Apr;104(4):
[PMID:
37018118]
Int J Infect Dis. 2024 Sep;146:107146
[PMID:
38945434]
Sci Rep. 2023 Sep 8;13(1):14789
[PMID:
37684332]
Cell Mol Life Sci. 2019 Feb;76(3):473-493
[PMID:
30317530]
Nutrients. 2022 Nov 22;14(23):
[PMID:
36500975]
Vet Res. 2017 Sep 15;48(1):49
[PMID:
28915920]
Sci Rep. 2021 May 3;11(1):9427
[PMID:
33941825]
Immunology. 2017 Aug;151(4):363-374
[PMID:
28542929]
Int J Mol Sci. 2024 Jan 19;25(2):
[PMID:
38279237]
Protein Cell. 2015 Jan;6(1):18-25
[PMID:
25384439]
Cell Metab. 2021 Nov 2;33(11):2260-2276.e7
[PMID:
34731656]
J Cell Mol Med. 2022 May;26(10):2766-2776
[PMID:
35343043]
J Virol. 2023 Jul 27;97(7):e0065623
[PMID:
37338411]
Animal. 2018 Mar;12(3):491-500
[PMID:
28766470]
Hum Vaccin Immunother. 2018;14(8):1840-1847
[PMID:
29641358]
Appl Environ Microbiol. 2002 Feb;68(2):608-15
[PMID:
11823198]
Emerg Infect Dis. 2021 Oct;27(10):2742-2745
[PMID:
34546164]
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1138-46
[PMID:
27151945]
Gut Microbes. 2021 Jan-Dec;13(1):1-28
[PMID:
33874858]
Genome Biol. 2020 Apr 28;21(1):99
[PMID:
32345342]
Nat Cancer. 2023 Oct;4(10):1491-1507
[PMID:
37723305]
Cell Rep. 2023 Nov 28;42(11):113409
[PMID:
37948179]
Gut Microbes. 2024 Jan-Dec;16(1):2340487
[PMID:
38626129]
Microbiome. 2024 Feb 5;12(1):20
[PMID:
38317217]
Gut Microbes. 2016 May 3;7(3):189-200
[PMID:
26963409]
Nat Commun. 2023 Feb 6;14(1):642
[PMID:
36746963]
Int Immunopharmacol. 2024 Jun 30;135:112285
[PMID:
38762922]
Mucosal Immunol. 2018 May;11(3):752-762
[PMID:
29411774]
J Gen Virol. 2019 Sep;100(9):1273-1281
[PMID:
31305236]
J Gen Microbiol. 1983 Oct;129(10):3227-37
[PMID:
6655460]
Nat Rev Microbiol. 2017 Jan;15(1):55-63
[PMID:
27694885]
J Virol. 2021 Mar 17;95(11):
[PMID:
33731452]
J Med Virol. 2023 Jan;95(1):e28242
[PMID:
36261874]
Lancet. 2008 Apr 26;371(9622):1464-75
[PMID:
18440429]
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584
[PMID:
28743984]
Cells. 2023 Mar 02;12(5):
[PMID:
36899929]
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S150-6
[PMID:
26595731]
Nutrients. 2018 Oct 13;10(10):
[PMID:
30322146]
Gut. 2022 Jun;71(6):1106-1116
[PMID:
35140064]
Eur Heart J. 2022 Feb 10;43(6):518-533
[PMID:
34597388]
Front Med. 2020 Feb;14(1):8-20
[PMID:
31989396]
Nat Microbiol. 2023 Jan;8(1):91-106
[PMID:
36604506]
Animals
Gastrointestinal Microbiome
Orthomyxoviridae Infections
Mice
Influenza A Virus, H1N1 Subtype
Lung
Influenza A Virus, H9N2 Subtype
Disease Models, Animal
Prevotella
Pentanoic Acids
Hemiterpenes